DaVita
DVA
#2385
Rank
S$9.94 B
Marketcap
S$139.09
Share price
1.96%
Change (1 day)
-42.31%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): S$13.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$12.64. In 2024 the company made an earnings per share (EPS) of S$14.03 an increase over its 2023 EPS that were of S$9.68.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$13.10-6.62%
2024S$14.0344.94%
2023S$9.6827.26%
2022S$7.61-35.56%
2021S$11.8144.1%
2020S$8.1919.7%
2019S$6.84540.48%
2018S$1.07-76.07%
2017S$4.47-19.31%
2016S$5.53242.52%
2015S$1.62-62.87%
2014S$4.3513.43%
2013S$3.848.45%
2012S$3.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$27.16 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$13.04 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$18.70 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.42-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA